This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
Greenberg, Howard
| Item Type | Name |
|
Concept
|
Pharmacokinetics
|
|
Academic Article
|
MK-0448, a specific Kv1.5 inhibitor: safety, pharmacokinetics, and pharmacodynamic electrophysiology in experimental animal models and humans.
|
|
Academic Article
|
Single- and multiple-dose pharmacokinetics of caspofungin in healthy men.
|
|
Academic Article
|
Pharmacokinetics of intramuscularly administered ertapenem.
|
|
Academic Article
|
Effects of aprepitant on the pharmacokinetics of ondansetron and granisetron in healthy subjects.
|
|
Academic Article
|
The pharmacokinetics of nebulized nanocrystal budesonide suspension in healthy volunteers.
|
|
Academic Article
|
The effects of modifying in vivo cytochrome P450 3A (CYP3A) activity on etoricoxib pharmacokinetics and of etoricoxib administration on CYP3A activity.
|
|
Academic Article
|
Pharmacokinetics of aprepitant after single and multiple oral doses in healthy volunteers.
|
|
Academic Article
|
Effects of ezetimibe on cyclosporine pharmacokinetics in healthy subjects.
|
|
Academic Article
|
The pharmacokinetics of taurolidine metabolites in healthy volunteers.
|
|
Academic Article
|
Effect of aprepitant on the pharmacokinetics of intravenous midazolam.
|
|
Academic Article
|
American College of Clinical Pharmacology position statement on the use of microdosing in the drug development process.
|
|
Academic Article
|
Human pharmacokinetics and interconversion of enantiomers of MK-0767, a dual PPARalpha/gamma agonist.
|
|
Academic Article
|
Minimal effects of ritonavir and efavirenz on the pharmacokinetics of raltegravir.
|
|
Academic Article
|
Simvastatin does not affect CYP3A activity, quantified by the erythromycin breath test and oral midazolam pharmacokinetics, in healthy male subjects.
|
|
Academic Article
|
In-vitro metabolism of celecoxib, a cyclooxygenase-2 inhibitor, by allelic variant forms of human liver microsomal cytochrome P450 2C9: correlation with CYP2C9 genotype and in-vivo pharmacokinetics.
|
|
Academic Article
|
Pharmacokinetics and safety of single intravenous infusions of the adenosine agonist, AMP 579, in patients with end-stage renal insufficiency.
|